 | Up a level |
Journal Article
Ortiz-Bruechle, N., Muders, M., Toma, M., Esposito, I, Hartmann, A., Stoehr, R., Reis, H., Wild, P., Koellermann, J., Bremmer, F., Leichsenring, J., Stenzinger, A., Merkelbach-Bruse, S., Kirfel, S., Perner, S., Hartmann, N., Roth, W., Jung, A., Kirchner, T., Schwamborn, K., Pfarr, N., Dahl, E., Knuechel, R. and Gaisa, N. T. (2020). Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group. Urologe, 59 (3). S. 318 - 326. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563
Weichert, W., Bartels, S., Baretton, G., Braicu, E. I., Demes, M. C., Endris, V., Herold, S., Heukamp, L., Hummel, M., Lehmann, U., Merkelbach-Bruse, S., Pfarr, N., Rad, R., Sehouli, J., Siemanowski, J., Stenzinger, A., von Schwarzenberg, K., Vollbrecht, C., Wild, P. and Zocholl, D. (2021). Concordance between multiple HRD assays is substantial in high-grade ovarian cancer. Ann. Oncol., 32. S. S747 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041